Literature DB >> 17384470

Activin A as a critical mediator of capillary formation: interaction with the fibroblast growth factor action.

Yoshiro Hayashi1, Kyoko Maeshima, Fumio Goto, Itaru Kojima.   

Abstract

The present study was conducted to elucidate the role of activin A in capillary formation. When bovine aortic endothelial cells (BAEC) were cultured in a collagen gel, basic fibroblast growth factor (FGF-2) induced tube formation. Activin A also induced tube formation and the addition of two factors together was more effective. BAEC produced both FGF-2 and activin A as autocrine factors. Exogenous FGF-2 did not affect the production of activin A but instead upregulated the type II activin receptor. On the other hand, activin A increased the expression of FGF-2 as well as the FGF receptor. Most importantly, when the action of endogenous activin A was blocked by adding follistatin, the tubulogenic action of FGF-2 was nearly completely inhibited. Activin-induced tubulogenesis was markedly inhibited by overexpression of Smad7, an inhibitory Smad. Similarly, an inhibitor of p44/42 mitogen-activated protein (MAP) kinase attenuated the activin-mediated tubulogenesis, whereas an inhibitor of p38 MAP kinase had no effect. These results indicate that FGF-2 and activin A enhance their signals each other in BAEC, and endogenous activin A is critical for FGF-2-induced capillary formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17384470     DOI: 10.1507/endocrj.k06-222

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  6 in total

Review 1.  The crosstalk of RAS with the TGF-β family during carcinoma progression and its implications for targeted cancer therapy.

Authors:  Michael Grusch; Michaela Petz; Thomas Metzner; Deniz Oztürk; Doris Schneller; Wolfgang Mikulits
Journal:  Curr Cancer Drug Targets       Date:  2010-12       Impact factor: 3.428

Review 2.  Medial arterial calcification in diabetes and its relationship to neuropathy.

Authors:  W J Jeffcoate; L M Rasmussen; L C Hofbauer; F L Game
Journal:  Diabetologia       Date:  2009-09-12       Impact factor: 10.122

3.  Female infertility and disrupted angiogenesis are actions of specific follistatin isoforms.

Authors:  Shyr-Yeu Lin; Rebecca G Craythorn; Anne E O'Connor; Martin M Matzuk; Jane E Girling; John R Morrison; David M de Kretser
Journal:  Mol Endocrinol       Date:  2007-10-11

4.  Effects of the Activin A-Follistatin System on Myocardial Cell Apoptosis through the Endoplasmic Reticulum Stress Pathway in Heart Failure.

Authors:  Miao Liu; Cuiying Mao; Jiayu Li; Fanglei Han; Ping Yang
Journal:  Int J Mol Sci       Date:  2017-02-10       Impact factor: 5.923

5.  Relationship of activin A levels with clinical presentation, extent, and severity of coronary artery disease.

Authors:  Nadia Bouzidi; Fethi Betbout; Faouzi Maatouk; Habib Gamra; Abdelhedi Miled; Salima Ferchichi
Journal:  Anatol J Cardiol       Date:  2017-12       Impact factor: 1.596

6.  Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy.

Authors:  Cornelia Schuster; Lars A Akslen; Tomasz Stokowy; Oddbjørn Straume
Journal:  J Pathol Clin Res       Date:  2018-11-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.